Gene Therapy in Ophthalmology Market Size
Market Size in USD Bn
CAGR25.4%
| Study Period | 2025-2032 |
| Base Year of Estimation | 2024 |
| CAGR | 25.4% |
| Market Concentration | High |
| Major Players | Johnson & Johnson Innovative Medicine, MeiraGTx, Beacon Therapeutics, Nanoscope Therapeutics, GenSight Biologics and Among Others |
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
Want to purchase customized report?
please let us know !
please let us know !
Gene Therapy in Ophthalmology Market Analysis
The gene therapy in ophthalmology market is estimated to be valued at USD 1.51 Bn in 2025 and is expected to reach USD 7.36 Bn by 2032, growing at a compound annual growth rate (CAGR) of 25.4% from 2025 to 2032. There is a rising trend seen in gene therapy to treat ophthalmic disorders. Manufacturers are involved in research and development of novel gene therapy products for ophthalmic conditions like age-related macular degeneration which has high prevalence rate.